C1q is shown to be expressed in neurons, where it acts as a signal for
synapse elimination. Methods are provided for protecting or treating an
individual suffering from adverse effects of synapse loss. These findings
have broad implications for a variety of clinical conditions, including
Alzheimer's disease.